Chest Pain, Normal Tests, Sent Home Again: What the Workup Is Missing in Men

A man in his mid-50s has had chest tightness with exertion for eight months. He has seen his doctor twice. He had a stress ECG, normal. He had a nuclear stress test, normal. At his follow-up, he was told his heart was fine and the pain was probably musculoskeletal or stress-related. He was given a referral to physical therapy and advised to manage his anxiety.

He is back in the emergency department at 2 AM with chest pain at rest, diaphoresis, and an ECG that shows transient ST elevation. The diagnosis is vasospastic angina, coronary artery spasm causing profound but reversible ischemia, in an artery that looks structurally normal on the angiogram the cardiologist orders at 3 AM.

The cardiac workup he received was appropriate for detecting obstructive coronary artery disease. It was not appropriate for detecting coronary artery spasm, microvascular dysfunction, or the other mechanisms that produce real ischemia in arteries without significant plaque. He was told he was fine. He was not fine. The evaluation was incomplete.

What a Standard Stress Test Actually Tests

Understanding what a normal stress test means, and does not mean, requires understanding what the test was designed to detect.

The exercise treadmill stress test measures the heart’s response to increasing workload. It detects ischemia when it is large enough to produce electrical changes on the ECG (ST segment depression) during peak exercise. For ECG changes to appear, a substantial portion of myocardium must become ischemic at maximal effort. This reliably happens when there is a large epicardial coronary artery with hemodynamically significant stenosis, typically 70 percent or greater in the left anterior descending, circumflex, or right coronary artery.

A nuclear stress test (SPECT myocardial perfusion imaging) adds perfusion information: a radiotracer is injected at rest and peak stress, and the images are compared for regional differences in tracer uptake. This is more sensitive than ECG alone for detecting regional ischemia from large-artery disease, but it uses semi-quantitative comparisons of regional uptake, meaning it detects ischemia that is regional and asymmetric. Diffuse, symmetric reductions in perfusion from microvascular dysfunction often appear normal on SPECT.

The result: a man with hemodynamically significant plaque in a large coronary artery will almost certainly have an abnormal stress test. A man with coronary artery spasm, which produces ischemia transiently and unpredictably, often at rest or in the morning rather than at peak exercise, will typically have a normal stress test. A man with coronary microvascular dysfunction will typically have a normal or near-normal SPECT. A man with esophageal spasm or musculoskeletal chest wall pain will have a normal stress test.

A normal stress test rules out one mechanism. It does not rule out all mechanisms. For a full account of what stress testing misses and why, see What a Stress Test Cannot Tell You.

The Four Categories That Normal Tests Miss in Men

When a man has recurrent chest pain and a normal standard cardiac workup, there are four categories to consider systematically rather than defaulting to a non-cardiac explanation.

Category 1: Coronary artery spasm (vasospastic angina)

Vasospastic angina involves episodic, transient constriction of a coronary artery, not from plaque obstruction but from pathological vasomotor reactivity of the arterial smooth muscle. Between episodes, the artery appears completely normal. During an episode, blood flow can be reduced to the point of profound ischemia, sometimes with ST elevation on ECG identical to STEMI.

The classic presentation is chest pain at rest, often at night or in the early morning hours when vasomotor tone is highest. But exertional spasm also occurs, and the distinction between effort-induced spasm and effort-induced plaque ischemia cannot be made clinically without provocative testing.

Risk factors for vasospastic angina in men include tobacco smoking (the dominant modifiable risk factor), cocaine use, and in some series, magnesium deficiency. Men who smoke and have exertional or rest chest pain with normal angiography have a high pretest probability of vasospastic angina.

Diagnosis requires provocative testing with intracoronary acetylcholine or ergonovine during catheterization. These agents provoke spasm in susceptible coronary arteries, reproducing the ischemia in a controlled setting. The test is performed at specialized centers and is not universally available. A positive response confirms the diagnosis; calcium channel blockers (particularly diltiazem and amlodipine) and nitrates are the treatment foundation. Smoking cessation is the single most important modifier of long-term prognosis.

Category 2: Coronary microvascular dysfunction (CMD)

CMD was addressed in detail in a companion article on this site (microvascular-angina-men). In summary: men with metabolic syndrome, insulin resistance, hypertension, or smoking history can develop impaired coronary microvascular vasodilation that produces exertional ischemia despite patent large arteries. Coronary flow reserve below 2.0 confirms the diagnosis; standard stress testing misses it because diffuse microvascular hypoperfusion does not produce the regional perfusion asymmetry that SPECT detects.

For the man with recurrent exertional chest pain and a normal stress test, CMD should be on the differential, particularly if he has any metabolic risk factors. Cardiac PET with absolute myocardial blood flow quantification is the most sensitive non-invasive test; invasive coronary function testing (CFR and IMR measurement during catheterization) is the gold standard.

Category 3: Esophageal disease

Esophageal spasm, gastroesophageal reflux disease (GERD) with atypical presentation, and achalasia can all produce chest pain that is clinically indistinguishable from cardiac ischemia, substernal pressure, exertional component, radiation to the jaw or arm, nocturnal occurrence. The esophagus and the heart share afferent pain pathways through the vagus nerve and dorsal horn of the spinal cord, which is why esophageal pain is felt in the chest and can radiate identically to cardiac pain.

Men have higher rates of erosive esophagitis and GERD-related complications than women. A man who describes chest pain that is also associated with eating, worse when lying flat, relieved by antacids, or accompanied by a sour taste or throat burning may have esophageal disease as the primary mechanism, but none of these features reliably exclude cardiac ischemia, and both mechanisms can coexist.

The appropriate evaluation for suspected esophageal contribution includes empirical proton pump inhibitor (PPI) trial for four to eight weeks. If chest pain resolves completely with acid suppression, esophageal etiology is the most likely explanation. If symptoms persist despite PPI therapy, esophageal spasm is possible and requires esophageal manometry for diagnosis. Esophageal spasm responds to calcium channel blockers and nitrates, the same agents used for vasospastic angina, which can sometimes create diagnostic confusion.

Category 4: Musculoskeletal and chest wall causes

Costochondritis (inflammation of the cartilage joining the ribs to the sternum), intercostal muscle strain, rib stress reactions, and thoracic outlet syndrome can all produce chest pain that is localized, reproducible with palpation or specific movements, and typically not exertional in the same way as ischemic pain. These causes are appropriately evaluated clinically, point tenderness on the sternum or chest wall, pain reproduced by pressing on specific ribs, pain changing with arm position.

The clinical distinction matters: musculoskeletal chest wall pain that is positionally and palpably reproducible is lower probability for cardiac etiology. Chest pain that has a consistent exertional threshold, is relieved by rest, radiates to the jaw or left arm, and is not reproducible on palpation is higher probability for cardiac etiology even with a normal stress test. When these characteristics are present, musculoskeletal reassurance is premature without completing the cardiac differential.

Why the Dismissal Pattern Is Different in Men

Women with chest pain and normal cardiac workup are frequently told their symptoms are anxiety. This is a documented and criticized pattern of sex-based dismissal in cardiology.

Men with chest pain and normal cardiac workup are typically dismissed differently: the symptoms are attributed to musculoskeletal causes, stress, or GI disease without the equivalent of a structured evaluation for the cardiovascular mechanism. The implicit reasoning is that a man with a normal stress test and “some stress in his life” has been adequately evaluated, because the predominant male cardiovascular concern (large-artery plaque disease) has been ruled out.

The consequence is the same in both sexes: a patient with real, mechanism-specific symptoms that have not been identified is sent home without a diagnosis. In men, the dismissal is less likely to be framed as psychiatric but equally likely to leave the underlying cardiac mechanism unaddressed.

The Systematic Approach to Recurrent Chest Pain After a Normal Stress Test

For a man who has had recurrent exertional chest pain, a normal ECG stress test, and either a normal nuclear stress test or no further workup, the structured next steps depend on the clinical picture:

Step 1: Characterize the symptom pattern precisely. Does the pain occur at rest as well as with exertion? Does it occur at a consistent workload or variably? Is it worse in the morning? Does it have any gastrointestinal accompaniments? Is it reproducible with palpation? The answers guide the differential more than the test results.

Step 2: For predominantly exertional symptoms with metabolic risk factors, consider cardiac PET or cardiac MRI with perfusion imaging for CMD. If non-invasive testing is inconclusive and symptoms are significant, invasive coronary function testing with CFR and IMR measurement is the next step.

Step 3: For predominantly rest symptoms, especially nocturnal or morning symptoms, especially in a smoker, consider provocative vasospasm testing. This requires discussion with an interventional cardiologist experienced in intracoronary acetylcholine testing. If catheterization was already performed and showed normal or near-normal arteries, ask whether provocative testing was included.

Step 4: For symptoms with gastrointestinal accompaniments, PPI trial for four to eight weeks with documented symptom tracking. If partial but not complete response, esophageal manometry to evaluate for esophageal spasm.

Step 5: For symptoms with positional and palpatory features, clinical musculoskeletal evaluation. If negative or incomplete response to musculoskeletal treatment, return to cardiac differential.

Tobacco, Cocaine, and Vasospasm: The Modifiable Risk Profile

Vasospastic angina has a documented pharmacological and toxicological trigger profile that is more concentrated in men than in the general population, and understanding these triggers is both diagnostically and therapeutically relevant.

Tobacco smoking is the dominant modifiable risk factor for coronary artery spasm. In published vasospasm series, including the CORONARY SPASM Registry and the data from the EROSION trial, the proportion of patients with documented vasospasm who were active smokers is consistently above 70 percent. The mechanism involves nicotine-mediated endothelial dysfunction (reduced nitric oxide production, increased endothelin release) that shifts coronary arterial smooth muscle toward a hyperreactive vasomotor state. Smokers who have exertional or rest chest pain with a normal angiogram have a substantially elevated pretest probability of vasospastic angina compared to non-smokers with the same symptom profile.

The clinical implication is direct: for a man who smokes and has recurrent chest pain with a normal stress test, vasospasm moves to the top of the differential, not the bottom. Smoking cessation is the single most important intervention for vasospastic angina beyond pharmacological treatment, and in some series, cessation alone has produced significant reduction in vasospastic episodes independent of calcium channel blocker therapy.

Cocaine is a discrete trigger category that deserves explicit mention. Cocaine produces intense coronary vasospasm in addition to its catecholamine-release effects, and cocaine-associated chest pain can be indistinguishable from ischemic pain from other causes. A man presenting with chest pain who has used cocaine, even occasionally, should have this in his clinical history, because the evaluation and management of cocaine-related coronary vasospasm differs from other vasospasm: coronary vasodilators are appropriate; beta-blockers without alpha-blockade are contraindicated (they unmask alpha-adrenergic vasoconstriction). The standard question in a chest pain history (“do you use any drugs?”) is often answered incompletely, and cocaine history specifically should be asked directly in men with unexplained chest pain and non-obstructive coronary anatomy. Men with cocaine-associated vasospasm who cease use consistently have better prognoses than those who continue, paralleling the smoking cessation benefit in non-cocaine-related vasospasm series.

The Risk of the “You’re Fine” Diagnosis

Being told you are fine when you are not is not a neutral outcome. It delays the correct diagnosis and, in some cases, allows a treatable condition to progress. Vasospastic angina, untreated, is associated with a 1 to 2 percent annual sudden death risk. Coronary microvascular dysfunction with a CFR below 2.0, untreated, is associated with major adverse cardiovascular event rates of 20 to 30 percent over five years. Neither condition is found by a normal stress test. Both require specific evaluation to identify and treat.

The man who has been reassured that his heart is fine based on a normal stress test and continues to have symptoms deserves persistent clinical engagement. The appropriate clinical response to persistent unexplained chest pain is not repeated reassurance, it is progressive evaluation until a mechanism is identified or a comprehensive investigation has been completed and documented as negative.

What to Do This Week

If you have had recurrent chest pain that was evaluated with a stress test and told “normal”, and the symptoms persist, the productive next question is not “why do I keep having chest pain if my heart is fine?” The productive question is: “What mechanism of chest pain has not yet been evaluated?”

Request a conversation with your cardiologist or primary care physician about the specific categories listed above. Ask explicitly whether coronary artery spasm has been considered and whether provocative testing is appropriate given your symptom pattern. Ask whether coronary microvascular dysfunction has been evaluated. Ask whether an esophageal cause has been systematically investigated.

If the answer to all of these is “no, because your stress test was normal,” that is a signal that the evaluation was screened for one mechanism and found nothing, not that all mechanisms were excluded.

A comprehensive chest pain evaluation in a man with recurrent symptoms and an initial normal stress test is not redundant. It is the continuation of a diagnostic process that the stress test only began.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.